Connect with us

CBD News

New Expanding Cannabis Research and Information Act Bill in Illinois Submitted by Illinois Senator

Published

on

New Expanding Cannabis Research and Information Act Bill in Illinois Submitted by Illinois Senator

A marijuana research bill has been introduced in the state of Illinois by Senator Dick Durbin. The bill will bypass federal barriers of marijuana research. The bill is titled the Expanding Cannabis Research and Information Act and seeks to dive deeper into the benefits of cannabis as well as the potential risks. Durbin stated that we need a better understanding of cannabis for treatment as well as how marijuana can affect public safety and specific populations. He highlights children, pregnant woman, and drivers as key groups.

Under current federal legislation, marijuana is still classified as a Schedule I controlled substance. This implies that it has no medical benefits. There are also numerous steps that researchers must follow to begin a marijuana-based research project. What researchers actually know and have proven scientifically is minimal due to these constraints. If the proposed act goes into effect, marijuana would be classified as a Schedule III controlled substance to remove research barriers. A national research agenda is also being developed to focus on the health benefits of cannabis.

Ella D. Hughes’ input strengthens the legal presence at TOC with her litigator nature and fondness with fitness and adamant cooking skills. During her undergraduate study, she dove deep into diverse fields of psychology, theater, evolutionary biology, psychopharmacology, and romance languages. After being admitted to the bar, TOC is leaning on Ella to help cover the rapidly evolving cannabis and hemp industries for legal insights and regulatory law feedback.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.